Glassman Wealth Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-349
| Closed | -$142K | – | 1785 |
|
2023
Q4 | $142K | Buy |
349
+4
| +1% | +$1.63K | 0.02% | 244 |
|
2023
Q3 | $120K | Buy |
345
+2
| +0.6% | +$695 | 0.02% | 246 |
|
2023
Q2 | $121K | Buy |
343
+1
| +0.3% | +$352 | 0.02% | 242 |
|
2023
Q1 | $108K | Buy |
342
+34
| +11% | +$10.7K | 0.02% | 254 |
|
2022
Q4 | $88.9K | Buy |
308
+11
| +4% | +$3.18K | 0.02% | 289 |
|
2022
Q3 | $86K | Buy |
297
+17
| +6% | +$4.92K | 0.02% | 270 |
|
2022
Q2 | $79K | Buy |
280
+47
| +20% | +$13.3K | 0.02% | 300 |
|
2022
Q1 | $61K | Sell |
233
-95
| -29% | -$24.9K | 0.01% | 360 |
|
2021
Q4 | $72K | Buy |
328
+218
| +198% | +$47.9K | 0.01% | 303 |
|
2021
Q3 | $20K | Buy |
110
+10
| +10% | +$1.82K | ﹤0.01% | 584 |
|
2021
Q2 | $20K | Sell |
100
-8
| -7% | -$1.6K | ﹤0.01% | 579 |
|
2021
Q1 | $23K | Buy |
108
+18
| +20% | +$3.83K | ﹤0.01% | 495 |
|
2020
Q4 | $21K | Sell |
90
-82
| -48% | -$19.1K | ﹤0.01% | 513 |
|
2020
Q3 | $47K | Buy |
172
+48
| +39% | +$13.1K | 0.01% | 305 |
|
2020
Q2 | $36K | Buy |
124
+33
| +36% | +$9.58K | 0.01% | 300 |
|
2020
Q1 | $22K | Sell |
91
-17
| -16% | -$4.11K | 0.01% | 330 |
|
2019
Q4 | $24K | Buy |
108
+3
| +3% | +$667 | 0.01% | 355 |
|
2019
Q3 | $18K | Buy |
105
+18
| +21% | +$3.09K | 0.01% | 374 |
|
2019
Q2 | $16K | Sell |
87
-9
| -9% | -$1.66K | 0.01% | 394 |
|
2019
Q1 | $18K | Buy |
96
+66
| +220% | +$12.4K | 0.01% | 370 |
|
2018
Q4 | $5K | Hold |
30
| – | – | ﹤0.01% | 437 |
|
2018
Q3 | $6K | Sell |
30
-3
| -9% | -$600 | ﹤0.01% | 463 |
|
2018
Q2 | $6K | Buy |
33
+5
| +18% | +$909 | ﹤0.01% | 427 |
|
2018
Q1 | $5K | Hold |
28
| – | – | ﹤0.01% | 434 |
|
2017
Q4 | $4K | Buy |
28
+3
| +12% | +$429 | ﹤0.01% | 441 |
|
2017
Q3 | $4K | Hold |
25
| – | – | ﹤0.01% | 378 |
|
2017
Q2 | $3K | Hold |
25
| – | – | ﹤0.01% | 404 |
|
2017
Q1 | $3K | Sell |
25
-68
| -73% | -$8.16K | ﹤0.01% | 432 |
|
2016
Q4 | $7K | Buy |
93
+89
| +2,225% | +$6.7K | 0.01% | 409 |
|
2016
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 590 |
|